FI852516L - Anordning foer dosering av tillvaext befraemjande aemnen. - Google Patents

Anordning foer dosering av tillvaext befraemjande aemnen.

Info

Publication number
FI852516L
FI852516L FI852516A FI852516A FI852516L FI 852516 L FI852516 L FI 852516L FI 852516 A FI852516 A FI 852516A FI 852516 A FI852516 A FI 852516A FI 852516 L FI852516 L FI 852516L
Authority
FI
Finland
Prior art keywords
tillvaext
befraemjande
dosering
aemnen
anording
Prior art date
Application number
FI852516A
Other languages
English (en)
Finnish (fi)
Other versions
FI852516A0 (fi
Inventor
Daniel M Linkie
Michael O Thorner
Original Assignee
Daniel M Linkie
Michael O Thorner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniel M Linkie, Michael O Thorner filed Critical Daniel M Linkie
Publication of FI852516A0 publication Critical patent/FI852516A0/fi
Publication of FI852516L publication Critical patent/FI852516L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/25Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/12Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI852516A 1984-06-29 1985-06-26 Anordning foer dosering av tillvaext befraemjande aemnen. FI852516L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/626,400 US4747825A (en) 1984-06-29 1984-06-29 Apparatus and methodology for pulsed administration of growth promoting agents

Publications (2)

Publication Number Publication Date
FI852516A0 FI852516A0 (fi) 1985-06-26
FI852516L true FI852516L (fi) 1985-12-30

Family

ID=24510242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852516A FI852516L (fi) 1984-06-29 1985-06-26 Anordning foer dosering av tillvaext befraemjande aemnen.

Country Status (16)

Country Link
US (1) US4747825A (pt)
EP (1) EP0190199A4 (pt)
JP (1) JPS61502519A (pt)
AU (1) AU4605385A (pt)
BE (1) BE902783A (pt)
BR (1) BR8506785A (pt)
DK (1) DK294685A (pt)
FI (1) FI852516L (pt)
IL (1) IL75671A0 (pt)
MW (1) MW686A1 (pt)
NO (1) NO852603L (pt)
OA (1) OA08214A (pt)
PT (1) PT80738B (pt)
RO (1) RO95012A (pt)
WO (1) WO1986000233A1 (pt)
ZA (1) ZA854916B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
US5065748A (en) * 1989-11-14 1991-11-19 University Of South Florida Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone
US5065747A (en) * 1989-11-21 1991-11-19 University Of South Florida Method for improving the accuracy of diagnosis of growth hormone deficiency
US5428013A (en) * 1991-01-04 1995-06-27 Mugica; Jesus D. Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
JP3971454B2 (ja) * 1993-10-29 2007-09-05 ザ トラスティーズ オブ ボストン ユニバーシティ 抗新生物剤としての酪酸、酪酸塩、および誘導体の生理学的に安定な組成物
EP0800405A4 (en) * 1994-12-19 1998-11-11 Beth Israel Hospital CONTINUOUS ADMINISTRATION OF LOW DOSES OF HORMONE PARATHYRO DIENNE OR ITS AGONIST
US6403647B1 (en) 1996-07-26 2002-06-11 Susan P. Perrine Pulsed administration of compositions for the treatment of blood disorders
EP2298350A3 (en) 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
US5939456A (en) * 1996-07-26 1999-08-17 Perrine; Susan P. Pulsed administration of compositions for the treatment of blood disorders
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
CA2324426A1 (en) * 1998-02-11 1999-08-19 Douglas V. Faller Compositions and methods for the treatment of cystic fibrosis
CA2498319A1 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20130017188A1 (en) 2009-07-31 2013-01-17 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
WO2011038224A1 (en) 2009-09-24 2011-03-31 Trustees Of Boston University Methods for treating viral disorders
CN102802412A (zh) 2009-12-08 2012-11-28 海玛奎斯特医药公司 用于治疗红细胞病症的方法及低剂量方案
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
US9428565B2 (en) 2011-01-31 2016-08-30 The General Hospital Corporation Treatment and bioluminescent visualization using multimodal TRAIL molecules
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
US9480696B2 (en) 2011-05-04 2016-11-01 Trustees Of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
WO2013082275A1 (en) 2011-11-30 2013-06-06 Trustees Of Boston College Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production
JP2015525781A (ja) 2012-07-31 2015-09-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 免疫応答の調節
EP2890720B1 (en) 2012-08-30 2019-07-17 The General Hospital Corporation Compositions and methods for treating cancer
CA2887528C (en) 2012-10-12 2023-08-29 The Brigham And Women's Hospital, Inc. Enhancement of the immune response
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
EP3036226B1 (en) 2013-08-22 2020-01-08 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
WO2015031765A2 (en) 2013-08-29 2015-03-05 Trustees Of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
CA2966352A1 (en) 2013-11-26 2015-06-04 The Brigham And Women's Hospital, Inc. Compositions and methods for modulating an immune response
WO2015089321A2 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
US20170107300A1 (en) 2014-03-21 2017-04-20 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
AU2015249666A1 (en) 2014-04-25 2016-11-17 The Brigham And Women's Hospital, Inc. Compositions and methods for treating subjects with immune-mediated diseases
CA2983794A1 (en) 2014-04-25 2015-10-29 The Brigham And Women's Hospital, Inc. Methods to manipulate alpha-fetoprotein (afp)
JP7095990B2 (ja) 2014-09-18 2022-07-05 シーダーズ-サイナイ メディカル センター 線維症を治療するための組成物及び方法
GB2557389B (en) 2015-01-14 2020-12-23 Brigham & Womens Hospital Inc Treatment of cancer with anti-lap monoclonal antibodies
WO2016172479A1 (en) 2015-04-22 2016-10-27 Cedars-Sinai Medical Center Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes
WO2016196664A1 (en) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Methods and use of compounds that bind to rela of nf-kb
US20180185345A1 (en) 2015-06-19 2018-07-05 Trustees Of Boston University Methods and compositions for treating herpesvirus induced conditions
BR112018001441A2 (pt) 2015-07-28 2018-09-11 Vyome Biosciences Pvt Ltd antibacterianos terapêuticos e profiláticos
US10702586B2 (en) 2015-09-28 2020-07-07 Children's Hospital Los Angeles Methods for treating diseases mediated by ErbB4-positive pro-inflammatory macrophages
WO2017069958A2 (en) 2015-10-09 2017-04-27 The Brigham And Women's Hospital, Inc. Modulation of novel immune checkpoint targets
US20200016202A1 (en) 2016-10-07 2020-01-16 The Brigham And Women's Hospital, Inc. Modulation of novel immune checkpoint targets
CA3090322A1 (en) 2018-02-12 2019-08-15 Diabetes-Free, Inc. Improved antagonistic anti-human cd40 monoclonal antibodies
WO2020102454A1 (en) 2018-11-13 2020-05-22 Regents Of The University Of Minnesota Cd40 targeted peptides and uses thereof
CN114206447A (zh) 2019-05-31 2022-03-18 维拉克塔附属公司 用组蛋白脱乙酰基酶抑制剂治疗病毒相关的癌症的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3498228A (en) * 1967-05-01 1970-03-03 Charles A Blumle Portable infusion pump
US3559644A (en) * 1967-12-14 1971-02-02 Robert F Shaw Liquid infusion apparatus
US3809871A (en) * 1972-12-01 1974-05-07 Nasa Programmable physiological infusion
US4273122A (en) * 1976-11-12 1981-06-16 Whitney Douglass G Self contained powered injection system
US4313439A (en) * 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
DE3015777A1 (de) * 1980-04-24 1981-10-29 Ferring Arzneimittel Gmbh, 2300 Kiel Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln
US4306553A (en) * 1980-07-22 1981-12-22 The Regents Of The University Of Minnesota Method of maintaining the fluidity of hormone solutions for parenteral administration
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
US4529595A (en) * 1983-01-13 1985-07-16 The Salk Institute For Biological Studies GRF Analogs

Also Published As

Publication number Publication date
BE902783A (fr) 1985-10-16
PT80738A (en) 1985-07-01
EP0190199A4 (en) 1987-12-01
BR8506785A (pt) 1986-11-25
US4747825A (en) 1988-05-31
MW686A1 (en) 1987-03-11
FI852516A0 (fi) 1985-06-26
AU4605385A (en) 1986-01-24
WO1986000233A1 (en) 1986-01-16
ZA854916B (en) 1986-02-26
DK294685D0 (da) 1985-06-28
RO95012A (ro) 1988-09-15
PT80738B (en) 1986-12-11
IL75671A0 (en) 1985-10-31
DK294685A (da) 1985-12-30
NO852603L (no) 1985-12-30
JPS61502519A (ja) 1986-11-06
EP0190199A1 (en) 1986-08-13
OA08214A (en) 1987-10-30

Similar Documents

Publication Publication Date Title
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
FI852265A0 (fi) Anordning foer oskillerande lineardrift av konstruktionsdelar.
FI861843A0 (fi) Drivanordning foer borrstaong speciellt foer utfoerande av kontinuerlig djupborrning.
FI844046L (fi) Foerfarande foer framstaellning av polytriaziner fraon aromatiska polycyanater.
FI862231A0 (fi) Anordning foer utkastning av spelbollar.
FI83882B (fi) Foerfarande foer framstaellning av blodlevring haemmande proteiner.
FI842544A0 (fi) Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
FI864365A0 (fi) Anordning foer spaonskaerande behandling av traedstammars sidor.
FI80896B (fi) Foerfarande foer framstaellning av fenolskum.
FI853050L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva kinolonkarboxylsyraderivat.
FI852552A0 (fi) Foerfarande foer framstaellning av l-fenylalanin.
FI862439A (fi) Foerfarande foer framstaellning av cellulosamassa.
FI851520L (fi) Anordning foer sammanpressning av en blaosfolieslang.
FI852437A0 (fi) Anordning foer framstaellning av tomografiroentgenbilder.
FI844493A0 (fi) Realtidsproevning av byggnaders vaederbeteende.
FI850187L (fi) Anlaeggning foer framstaellning av formsten av skumbetong.
FI850226A0 (fi) Foerfarande foer framstaellning av leukotrienantagonister.
FI850758A0 (fi) Foerfarande foer framstaellning av 3-metyl-7-fluor-5-nitrobenzotiofen.
FI852871L (fi) Foerfarande foer framstaellning av kompositioner.
FI881266A0 (fi) Anordning foer belysning av flaggor.
FI845082A0 (fi) Anordning foer rengoerning av skor.
FI841919A0 (fi) Anordning foer roerande av arbetsmaskins bomraecka.
FI842003A (fi) Anordning foer dragande av skidspaor.
FI842102A0 (fi) Anordning foer foerhindrande av ljusbaogeskador.
FI842673A0 (fi) Anordning speciellt foer behandling av avfallsvatten.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THORNER, MICHAEL M.

Owner name: LINKIE, DANIEL M.